Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Histone Modification02:32

Histone Modification

17.2K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
17.2K
Histone Modification02:32

Histone Modification

4.9K
4.9K
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

10.0K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
10.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TET CpG sequence-context-specific DNA demethylation shapes progression of IDH-mutant gliomas.

Cell reports. Medicine·2026
Same author

E2F1 K117 methylation by SETD6 disrupts BRD4-E2F1 binding and modulates E2F1 chromatin binding and gene regulation in prostate cancer cells.

Nucleic acids research·2026
Same author

Nucleosome linker DNA methylation by DNMT3A/DNMT3B3 is controlled by nucleosome binding and multimerization of DNMT3 complexes on DNA.

The Journal of biological chemistry·2026
Same author

Tumors with mutations in chromatin regulators are associated with higher mutational burden and improved response to checkpoint immunotherapy.

Clinical epigenetics·2025
Same author

Mechanisms of Substrate Recognition by the Multispecific Protein Lysine Methyltransferase SETD6.

Life (Basel, Switzerland)·2025
Same author

A population model reveals a surprising role of stochastic cell division in epigenetic memory systems.

iScience·2025

Related Experiment Video

Updated: Mar 30, 2026

Author Spotlight: Enhanced Histone PTM Isomer Identification Through LC-TIMS-ToF MS/MS and PASEF
05:52

Author Spotlight: Enhanced Histone PTM Isomer Identification Through LC-TIMS-ToF MS/MS and PASEF

Published on: January 12, 2024

1.8K

Affinity reagents for studying histone modifications & guidelines for their quality control.

Goran Kungulovski1, Rebekka Mauser1, Albert Jeltsch1

  • 1Institute of Biochemistry, Stuttgart University, Pfaffenwaldring 55, 70569 Stuttgart, Germany.

Epigenomics
|November 7, 2015
PubMed
Summary

This review updates quality criteria for histone post-translational modification (PTM) affinity reagents. It evaluates antibodies and recombinant reading domains for reliable chromatin biology research.

Keywords:
ChIPantibodieshistone modificationsnucleosomequality controlreading domainsspecificity

More Related Videos

Purification of H3 and H4 Histone Proteins and the Quantification of Acetylated Histone Marks in Cells and Brain Tissue
09:43

Purification of H3 and H4 Histone Proteins and the Quantification of Acetylated Histone Marks in Cells and Brain Tissue

Published on: November 30, 2018

22.4K
Assays for Validating Histone Acetyltransferase Inhibitors
09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

7.1K

Related Experiment Videos

Last Updated: Mar 30, 2026

Author Spotlight: Enhanced Histone PTM Isomer Identification Through LC-TIMS-ToF MS/MS and PASEF
05:52

Author Spotlight: Enhanced Histone PTM Isomer Identification Through LC-TIMS-ToF MS/MS and PASEF

Published on: January 12, 2024

1.8K
Purification of H3 and H4 Histone Proteins and the Quantification of Acetylated Histone Marks in Cells and Brain Tissue
09:43

Purification of H3 and H4 Histone Proteins and the Quantification of Acetylated Histone Marks in Cells and Brain Tissue

Published on: November 30, 2018

22.4K
Assays for Validating Histone Acetyltransferase Inhibitors
09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

7.1K

Area of Science:

  • Chromatin biology
  • Molecular biology
  • Epigenetics

Background:

  • Histone post-translational modifications (PTMs) regulate crucial chromatin processes.
  • Accurate detection of histone PTMs is essential for understanding chromatin function.
  • Current methods rely on affinity reagents like antibodies and recombinant reading domains.

Purpose of the Study:

  • To evaluate and update quality criteria for assessing the binding specificity of histone PTM affinity reagents.
  • To discuss the advantages and disadvantages of using antibodies versus recombinant reading domains.
  • To provide guidance for selecting appropriate reagents in chromatin biology research.

Main Methods:

  • Review of existing literature on histone PTM detection methods.
  • Evaluation of quality criteria for affinity reagent specificity.
  • Comparative analysis of antibodies and recombinant reading domains.

Main Results:

  • Established approaches for histone PTM characterization depend on affinity reagents.
  • The performance of these reagents is critical for experimental validity.
  • Updated quality criteria are proposed for assessing reagent specificity.

Conclusions:

  • Recombinant reading domains offer advantages like consistent quality and recombinant production.
  • Antibodies have established roles but can present challenges.
  • The emerging technology of reading domains holds promise for future chromatin biology research.